Actionable news
All posts from Actionable news
Actionable news in AMRI: Albany Molecular Research, Inc.,

GTCR, Carlyle to buy contract research firm Albany Molecular

A general view of the lobby outside of the Carlyle Group offices in Washington, May 3, 2012.

Contract drug manufacturer and research company Albany Molecular Research Inc (AMRI.O) said on Tuesday it agreed to be taken private by buyout firms Carlyle Group LP (CG.O) and GTCR LLC for about $922 million in cash.

Albany Molecular's stockholders will receive $21.75 for each share they hold, representing a premium of about 10 percent to the stock's Monday...